Our Time: A Call to Save Preventable Death From Cardiovascular Disease (Heart Disease and Stroke)
Together, the Global Cardiovascular Disease Taskforce calls on the CVD community to endorse and support the top 4 widely supported exposure targets (Table 1) on physical inactivity, hypertension/blood pressure, dietary salt intake, and tobacco as those required to achieve the overarching goal of a 2...
Gespeichert in:
Veröffentlicht in: | Journal of the American College of Cardiology 2012-12, Vol.60 (22), p.2343-2348 |
---|---|
Hauptverfasser: | , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Together, the Global Cardiovascular Disease Taskforce calls on the CVD community to endorse and support the top 4 widely supported exposure targets (Table 1) on physical inactivity, hypertension/blood pressure, dietary salt intake, and tobacco as those required to achieve the overarching goal of a 25% reduction in premature mortality by 2025.\n Writing Group Member Employment Research Grant Other Research Support Speakers' Bureau/Honoraria Expert Witness Ownership Interest Consultant/Advisory Board Other Sidney C. Smith, Jr University of North Carolina None None None None None None None Amy Collins World Heart Federation None None None None None None None Roberto Ferrari University of Ferrara Boehringer Ingelheim[dagger]; Novartis[dagger]; Roche[dagger]; Servier[dagger] None Boehringer Ingelheim*; Roche*; Servier[dagger] None None Servier[dagger] None David R. Holmes, Jr Mayo Clinic None None None None None None None Susanne Logstrup European Heart Network None None None None None None None Diana Vaca McGhie American Heart Association None None None None None None None Johanna Ralston World Heart Federation None None None None None None None Ralph L. Sacco University of Miami Miller School of Medicine None None None None None None None Hans Stam Dutch Heart Foundation None None None None None None None Kathryn Taubert World Heart Federation None None None None None None None David A. Wood Imperial College London AstraZeneca[dagger]; Bristol-Myers Squibb[dagger]; Emea Sari[dagger]; MSD[dagger]; GlaxoSmithKline[dagger]; Novartis[dagger]; Pfizer Pharmaceuticals[dagger]; Roche[dagger] None AstraZeneca*; Kowa*; MSD* None MyAction Ltd.[dagger] Merck Sharp & Dohme* None William Zoghbi TMH Physician Organization None None None None None None None * Writing Group Disclosures This table represents the relationships of writing group members that may be perceived as actual or reasonably perceived conflicts of interest as reported on the Disclosure Questionnaire, which all members of the writing group are required to complete and submit. |
---|---|
ISSN: | 0735-1097 1558-3597 |
DOI: | 10.1016/j.jacc.2012.08.962 |